Ophthalmology
Second Sight Announces First Commercial Implant of Retinal Prosthesis
November 2, 2011 8:05 pm | News | CommentsLAUSANNE, Switzerland--(BUSINESS WIRE)--Second Sight Medical Products, Inc., the world's leading developer of retinal prostheses for the blind, announced that the first ever commercial implantation of such a prosthesis was successfully completed on Saturday, October 29th in Pisa, Italy.
Second Sight Wins 2011 World Technology Award
October 27, 2011 11:41 am | News | CommentsLOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc., the world's leading developer of retinal prostheses for the blind, announced that the company was honored as the 2011 winner of the World Technology Award for Health and Medicine at a gala event to close the 2011 World Technology Summit.
First Patient Enrolled in SARcode Bioscience's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution
September 14, 2011 10:37 am | by Bio-Medicine.Org | News | CommentsBRISBANE, Calif., Sept. 14, 2011 /- SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today that the initial patient has been enrolled in the company's pivotal Phase 3 clinical study (OPUS-1) of SAR 1118 ophthalmic solution. (Logo:...
Avedro scores FDA advancement for eye disease treatment
September 12, 2011 8:37 am | by Mass High Tech: The Journal of New England Technology | News | CommentsWaltham ophthalmologic device and pharmaceutical developer Avedro Inc. has been granted orphan drug designation by the U.S. FDA for its treatment of keratoconus, a degenerative eye disease found to be the leading cause of corneal transplants in the U.S.
NeurOptics Introduces First Hand-held Variable Light Condition Pupillometer to Optimize Outcomes for Refractive Surgery and Premium Intraocular Lens Candidates
September 7, 2011 10:37 am | by Bio-Medicine.Org | News | CommentsIRVINE, Calif., Sept. 7, 2011 /- NeurOptics, the worldwide leader in pupillometry, today announced the availability of the new VIP™-200 Variable Pupillometer for the measurement of pupil size under varying light conditions to enhance opportunities for successful outcomes for...
Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
August 22, 2011 9:50 am | by Bio-Medicine.Org | News | CommentsSANTA ANA, Calif., Aug. 22, 2011 /- Abbott (NYSE: ABT ) announced today that it has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs) with the European CE Mark of Healon EndoCoat OVD. The clear, viscous, low molecular weight dispersive OVD is intended for...
InspireMD Elects Two New Board Members
August 11, 2011 6:46 am | by Bio-Medicine.Org | News | CommentsTEL-AVIV, Israel, Aug. 11, 2011 /- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced the election of two proven leaders to the Company's board of directors. Paul S. Stuka, Managing Member of Osiris...
Covidien board OKs $2B stock buyback
August 11, 2011 5:43 am | by Mass High Tech: The Journal of New England Technology | News | CommentsCovidien plc, the Irish health care products company with U.S. headquarters in Mansfield, has been given approval by its board for a $2 billion stock repurchase program.
Ensuring Connectivity for Reliable Home Monitoring of Age-Related Macular Degeneration
August 3, 2011 6:01 am | by Gwenn Larsson | Articles | CommentsPatients with age-related macular degeneration (AMD) are at a high risk for vision loss. However, new wireless technology can aid the preservation of eyesight. Using cellular technology provided by Telenor Connextion, Notal Vision has recently enhanced its ForseeHome AMD Monitor, the first FDA cleared telemedicine device for monitoring the vision of patients with AMD. Equipped with psychophysical testing and wireless communication, the ForeseeHome operates as a home-based monitoring technology capable of saving one’s eyesight.
R A E N Optics Launches New Website and Releases New Styles
July 28, 2011 2:43 pm | by Bio-Medicine.Org | News | CommentsENCINITAS, Calif., July 28, 2011 /PRNewswire-iReach/ -- Encinitas, CA-based boutique eyewear brand, R A E N optics has the 2011 season in full focus with today's launch of their new website. A fresh look with optimized user capability, R A E N invites the World Wide Web to explore art,...
Subminiature LVDT Linear Position Sensor Serves as Critical Component in Ophthalmic Ultrasound System
July 25, 2011 11:21 am | by Eileen Otto & Jean Carl | Articles | CommentsThe Eye Cubed has been released by Ellex Innovative Imaging, which manufactures ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye diseases. A major element of the Eye Cubed is the MD 188 Series Sub-miniature LVDT Position Sensor by Macro Sensors. In conjunction with CT or MRI, the Eye Cubed is used for imaging orbital tumors and optic nerve abnormalities. It can also locate foreign bodies that become lodged in the eye.
SARcode Bioscience Completes $44 Million Series B Financing
July 18, 2011 4:42 am | by Bio-Medicine.Org | News | CommentsBRISBANE, Calif., July 18, 2011 /- SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing...
Two Patients Undergo Stem-Cell Blindness Treatment
July 14, 2011 5:34 am | by Massachusetts Institute of Technology | News | CommentsA small biotech firm is the second company to start human tests of embryonic stem-cell therapy.
Med device maker Avedro raises $25M
July 7, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | News | CommentsOphthalmologic device and pharmaceutical developer Avedro Inc. reported today that it has raised $25 million in a Series C financing round led by SCP Vitalife and Aperture Venture Partners.
Pepto-Bismol and Nick Cannon Heat Things up at this Year's Nathan's Famous Fourth of July International Hot Dog Eating Contest
June 27, 2011 11:33 am | by Bio-Medicine.Org | News | CommentsCINCINNATI, June 27, 2011 /- Pepto-Bismol announced today that for the second year in a row, Independence Day is marked by red, white and … PINK? In an act of true gastro-patriotism, Pepto-Bismol has decided to be the stomach-remedy sponsor of the Nathan's Famous Fourth of July...
BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
June 23, 2011 6:47 am | by Bio-Medicine.Org | News | CommentsNOVATO, Calif., June 23, 2011 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that it has entered into a definitive agreement to acquire a bulk biologics manufacturing plant from Pfizer, located in Shanbally, Cork, Ireland. The plant, which was completed and...
Alexion tests treatment to respond to Germany's E. coli outbreak
June 20, 2011 11:40 am | by Mass High Tech: The Journal of New England Technology | News | CommentsIn response to an Enterohemorrhagic E. coli outbreak that hit Germany beginning in May, Alexion Pharmaceuticals Inc. and Alexion Pharma International SÃ rl have been approved by German regulators to begin a clinical trial of Soliris as a treatment for Shiga-toxin producing E. coli...
Alexion tests treatment to respond to Germany's E.coli outbreaks
June 20, 2011 10:44 am | by Mass High Tech: The Journal of New England Technology | News | CommentsIn response to an Enterohemorrhagic E.coli outbreak that hit Germany beginning in May, Alexion Pharmaceuticals Inc. and Alexion Pharma International SÃ rl have been approved by German regulators to begin a clinical trial of Soliris as a treatment for Shiga-toxin producing E. coli hemolytic...
Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®
June 14, 2011 9:35 am | by Bio-Medicine.Org | News | CommentsRICHMOND, Texas, June 14, 2011 /- OCuSOFT, Inc., an ophthalmic pharmaceutical research, development and supply company today announced an exclusive multiyear agreement with Ardeo Health, LLC to distribute a novel dry eye therapy under license from Novagali Pharma S.A. of Evry, France,...
Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner in the Radiological and Electromechanical Devices Category
June 2, 2011 9:34 am | by Bio-Medicine.Org | News | CommentsANGLETON, Texas, June 2, 2011 /- Benchmark Electronics, Inc. (NYSE: BHE ), a leading integrated contract manufacturing provider, announced today that a product it helped commercialize and currently manufactures has won a 2011 Medical Design Excellence Awards. The Avedro Vedera KXS Vision...
Bio-Tissue Reaches Major Milestone
June 1, 2011 6:34 am | by Bio-Medicine.Org | News | CommentsMIAMI, June 1, 2011 /- Bio-Tissue, the industry leader in Ophthalmic tissue products, announced today that it has shipped over 7,500 ProKera® units since the product's inception. ProKera® is the only medical device that can provide wound healing to over 350,000 annual...
Shire buys Advanced BioHealing for $750M
May 17, 2011 2:35 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsAdvanced BioHealing Inc., the Connecticut biotech that filed for a $200 million IPO at the beginning of May, has been scooped up before its IPO for $750 million cash by Shire plc, the Irish company with its Human Genetic Therapies business presence in Lexington.
NEW Ocudoxâ„¢ Convenience Kit Now Available in Pharmacies for Immediate Dispensing
April 28, 2011 9:35 am | by Bio-Medicine.Org | News | CommentsRICHMOND, Texas, April 28, 2011 /- OCuSOFT, Inc., an ophthalmic research, development, and supply company is pleased to announce the availability of prescription-only (Rx) Ocudox™ Convenience Kit for immediate dispensing at most retail pharmacies including, but not limited to:...
Visian® ICL and Toric ICL V4c Receive CE Mark Approval
April 25, 2011 3:35 am | by Bio-Medicine.Org | News | CommentsMONROVIA, Calif., April 25, 2011 /- STAAR Surgical Company (NASDAQ: STAA ), the leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses for refractive surgery, today announced CE Mark approval for its Visian® Implantable Collamer® Lens (ICL™)...
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
April 20, 2011 9:36 pm | by Bio-Medicine.Org | News | CommentsTHOUSAND OAKS, Calif. and BRUSSELS, April 21, 2011 /- Amgen (NASDAQ: AMGN ) and UCB (Euronext Brussels: UCB) announced today positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low bone mineral...
